Raymond James & Associates’s Loxo Oncology, Inc LOXO Stock Holding History

Raymond James & Associates’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-15,638	Closed	-$2.19M	–	3768
2018 Q4	$2.19M	Buy	15,638 +10,218	+189%	+$1.55M	﹤0.01%	1590
2018 Q3	$926K	Buy	+5,420	New	+$911K	﹤0.01%	2304

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Raymond James & Associates's LOXO Position: Q1 2019 in Review

Raymond James & Associates sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 15,638 shares — an estimated $2.19M sold.

Raymond James & Associates first reported a position in LOXO in Q3 2018 and held it in 2 quarters. The position peaked at $2.19M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Raymond James & Associates reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Raymond James & Associates sold 15,638 Loxo Oncology, Inc shares in Q1 2019, an estimated $2.19M.
Raymond James & Associates first reported a position in Loxo Oncology, Inc in Q3 2018 and held it in 2 quarters.
Raymond James & Associates's Loxo Oncology, Inc position peaked at $2.19M in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.